Efficacy of individual cognitive rehabilitation for adult cancer survivors: A pilot study

Not Applicable

Completed

• Conditions: Cognitive Decline; Cancer; Cancer - Any cancer; Mental Health - Studies of normal psychology, cognitive function and behaviour

• Registration Number: ACTRN12621001015831
• Lead Sponsor: Griffith University

Brief Summary

Results indicated delivery of ReCogI within individual practice is achievable. Participants reported satisfaction with the content and delivery style of this program and reported one-on-one sessions are valuable due to the versatility and individualised approach. This satisfaction was higher than some small-group delivery (Green et al., 2017) and similar to web-based delivery (Mihuta et al., 2017). Participant outcomes on measure feedback was not commented on in the satisfaction survey. There is also evidence of reliable and clinical change for all participants in at least two perceived symptoms. However, a larger sample in required to ensure this program can be generalised to a diverse population. Overall, this research indicates that ReCogI shows promising preliminary evidence for assisting adult cancer survivors who experience cancer-related cognitive impairment.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-08-29
• Study Start: 2021-08-04
• Last Update Posted: 10 August 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 4

Inclusion Criteria

Inclusion criteria are: 18 years and older; fluent in English; previous diagnosis of adult-onset cancer; completion of primary treatments such as surgery, chemotherapy, and radiotherapy; and on a stable dose for at least 2 months for any long-term medication, such as hormonal or targeted therapies.

Exclusion Criteria

Exclusion criteria are: childhood cancer history; known primary or secondary central nervous system tumour; current mental disorder that would interfere with the ability to give informed consent and/or participate in the intervention; and history of intracranial radiotherapy or intrathecal chemotherapy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v2.0 Cognitive Function 8a (PROMIS-CF) self-report measure[3 or 4 timepoints prior to commencing intervention dependent on which baseline the participant is allocated, each occurring seven days apart. Then completed each week of the intervention being implemented seven days apart for four intervention modules.];PROMIS Short Form v2.0 Cognitive Function Abilities Subset 8a (PROMIS-CFA) self-report measure[3 or 4 timepoints prior to commencing intervention dependent on which baseline the participant is allocated, each occurring seven days apart. Then completed each week of the intervention being implemented seven days apart for four intervention modules.]